Live from the NIH registry
Studies recruiting near Huntsville right now
Top 25 of 92 recruiting studies, sorted by proximity — each links to its official registry page
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
Major Depressive Disorder, Suicidal Ideas
N/A
Interventional 240 participants sought
UAB Huntsville Regional Medical Campus — Huntsville, Alabama (3.9 mi)
· Sponsor: University of Alabama at Birmingham
Evaluating Stairway Designs for Individuals With Vision Impairment
Vision, Low, Mobility Limitation
N/A
Interventional 65 participants sought
University of Alabama in Huntsville — Huntsville, Alabama (3.9 mi)
· Sponsor: The University of Alabama in Huntsville
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 120 participants sought
Clearview Cancer Institute (Crestwood) — Huntsville, Alabama (3.9 mi)
· Sponsor: Pfizer
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
Normal and Diseased Tissue and Body Fluids Samples
N/A
Observational 100,000 participants sought
St. Jude Clinic at Huntsville Hospital for Women & Children — Huntsville, Alabama (3.9 mi)
· Sponsor: St. Jude Children's Research Hospital
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
Bipolar I Disorder, Bipolar II Disorder
Phase 2
Interventional 195 participants sought
University of Alabama - Huntsville Regional Medical Campus /ID# 272951 — Huntsville, Alabama (3.9 mi)
· Sponsor: AbbVie
Tracking Results of Ablations to Combat AF Registry Generation 2
Atrial Fibrillation
N/A
Observational 10,000 participants sought
Huntsville Hospital — Huntsville, Alabama (3.9 mi)
· Sponsor: AtriCure, Inc.
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
Atherosclerosis, Coronary Artery Disease
Phase 2
Interventional 456 participants sought
Heart Center Research, LLC — Huntsville, Alabama (3.9 mi)
· Sponsor: Beijing Inno Medicine Co., Ltd.
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Agitation, Alzheimer Disease
Phase 2
Interventional 120 participants sought
University of Alabama - Huntsville Regional Medical Campus — Huntsville, Alabama (3.9 mi)
· Sponsor: Celgene
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Small Cell Lung Cancer Metastatic or Locally Advanced, Neuroendocrine Cancer
Phase 1
Interventional 120 participants sought
Clearview Cancer Institute — Huntsville, Alabama (3.9 mi)
· Sponsor: SystImmune Inc.
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
Heart Failure, Congestive
Phase 4
Interventional 80 participants sought
Heart Center Research, LLC — Huntsville, Alabama (3.9 mi)
· Sponsor: Heart Center Research, LLC
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Heart Failure and Impaired Kidney Function
Phase 3
Interventional 4,800 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: AstraZeneca
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Proteinuric Kidney Diseases
Phase 2
Interventional 132 participants sought
Nephrology Consultants, LLC — Huntsville, Alabama (3.9 mi)
· Sponsor: Boehringer Ingelheim
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Diabetic Kidney Disease (DKD)
Phase 2
Interventional 270 participants sought
Apogee Clinical Research, LLC — Huntsville, Alabama (3.9 mi)
· Sponsor: Regeneron Pharmaceuticals
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD)
Phase 2
Interventional 315 participants sought
University of Alabama - Huntsville Regional Medical Campus /ID# 267818 — Huntsville, Alabama (3.9 mi)
· Sponsor: AbbVie
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Nephrology Consultants, LLC — Huntsville, Alabama (3.9 mi)
· Sponsor: CSL Behring
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
COVID-19, COVID
N/A
Interventional 1,000 participants sought
AFC Madison — Madison, Alabama (6.1 mi)
· Sponsor: Aptitude Medical Systems
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
Phase 1, Phase 2
Interventional 231 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: AstraZeneca
Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
Healthy Aging
N/A
Interventional 70 participants sought
Nutraceuticals Research Institute — Huntsville, Alabama (3.9 mi)
· Sponsor: Nutraceuticals Research Institute
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Huntsville, Alabama (3.9 mi)
· Sponsor: Medtronic
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Aortic Stenosis, Calcific, Aortic Valve Stenosis
N/A
Interventional 2,250 participants sought
Heart Center LLC, Huntsville — Huntsville, Alabama (3.9 mi)
· Sponsor: Edwards Lifesciences
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Major Depressive Disorder
Phase 2
Interventional 164 participants sought
University of Alabama at Birmingham-Huntsville — Huntsville, Alabama (3.9 mi)
· Sponsor: Syndeio Biosciences, Inc
Continuous Dual Aspiration Technique With Zoom System for Stroke
Ischemic Stroke, Acute Stroke
N/A
Observational 750 participants sought
Huntsville Hospital — Huntsville, Alabama (3.9 mi)
· Sponsor: Imperative Care, Inc.
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Kidney Disease, Chronic
Phase 3
Interventional 11,000 participants sought
Apogee Clinical Research — Huntsville, Alabama (3.9 mi)
· Sponsor: Boehringer Ingelheim
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Clostridoides Difficile Associated Disease
Phase 3
Interventional 32,500 participants sought
Medical Affiliated Research Center — Huntsville, Alabama (3.9 mi)
· Sponsor: Pfizer
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Moderate Aortic Valve Stenosis
Phase 2, Phase 3
Interventional 1,276 participants sought
Heart Center Research LLC — Huntsville, Alabama (3.9 mi)
· Sponsor: Kardigan, Inc.